A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies

EJNMMI Research

Volumn 2, Issue 1, 2012, Pages 1-9

  Oliveira, Sabrina ^a,b   Cohen, Ruth ^c   van Walsum, Marijke Stigter ^c   van Dongen, Guus A M S ^c   Elias, Sjoerd G ^b   van Diest, Paul J ^b   Mali, Willem ^b   van Paul, M P ^a   Henegouwen, Bergenen ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibodies; Biodistribution studies; EGFR; Optical molecular imaging; Tracer quantification

Indexed keywords

CETUXIMAB; FLUORESCENT DYE; UNCLASSIFIED DRUG; ZIRCONIUM 89; ZIRCONIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG LABELING; EX VIVO STUDY; FEMALE; FLUORESCENCE; FLUORESCENCE IMAGING; GAMMA RADIATION; INTERMETHOD COMPARISON; MOUSE; NEAR INFRARED FLUORESCENCE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION MEASUREMENT; RADIOACTIVITY; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

EID: 84871717195     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-2-50     Document Type: Article

References (24)

1. Ntziachristos V, Bremer C, Weissleder R: Fluorescence imaging with nearinfrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003, 13:195-208.
2. Hillman EM, Amoozegar CB, Wang T, McCaslin AF, Bouchard MB, Mansfield J, Levenson RM: In vivo optical imaging and dynamic contrast methods for biomedical research. Philos Transact A Math Phys Eng Sci 2011, 369:4620-4643.
3. Ntziachristos V: Clinical translation of optical and optoacoustic imaging. Philos Transact A Math Phys Eng Sci 2011, 369:4666-4678.
4. Keereweer S, Hutteman M, Kerrebijn JD, van de Velde CJ, Vahrmeijer AL, Lowik CW: Translational optical imaging in diagnosis and treatment of cancer. Curr Pharm Biotechnol 2012, 13:498-503.
5. Gioux S, Choi HS, Frangioni JV: Image-guided surgery using invisible nearinfrared light: fundamentals of clinical translation. Mol Imaging 2010, 9:237-255.
6. Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL: The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 2011, 104:323-332.
7. Oliveira S, van Dongen GA, Stigter Van Walsum M, Roovers RC, Stam JC, Mali W, van Diest PJ, van Bergen En Henegouwen PM: Rapid visualization of human tumor xenografts through optical imaging with a nearinfrared fluorescent anti-epidermal growth factor receptor nanobody. Mol Imaging 2012, 11:33-46.
8. Cohen R, Stammes MA, de Roos IH, Stigter Van Walsum M, Visser GW, van Dongen GA: Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. EJNMMI 2011, 1:31-43.
9. Gong H, Kovar J, Little G, Chen H, Olive DM: In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia 2010, 12:139-149.
10. Zhao D, Stafford JH, Zhou H, Thorpe PE: Near-infrared optical imaging of exposed phosphatidylserine in a mouse glioma model. Transl Oncol 2011, 4:355-364.
11. Hou Y, Liu Y, Chen Z, Gu N, Wang J: Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging. J Nanobiotechnology 2010, 8:25-38.
12. Marshall MV, Draney D, Sevick-Muraca EM, Olive DM: Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol 2010, 12:583-594.
13. Harding J, Burtness B: Cetuximab: an epidermal growth factor receptor chimeric human-murine monoclonal antibody. Drugs Today 2005, 41:107-127.
14. Milenic DE, Wong KJ, Baidoo KE, Ray GL, Garmestani K, Williams M, Brechbiel MW: Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications. Cancer Biother Radiopharm 2008, 23:619-631.
15. Mishani E, Abourbeh G, Eiblmaier M, Anderson CJ: Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Curr Pharm Des 2008, 14:2983-2998.
16. de Jong HW, van Velden FH, Kloet RW, Buijs FL, Boellaard R, Lammertsma AA: Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner. Phys Med Biol 2007, 52:1505-1526.
17. Loening AM, Gambhir SS: AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003, 2:131-137.
18. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
19. Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res 1999, 8:135-160.
20. Perk LR, Visser GW, Vosjan MJ, Stigter Van Walsum M, Tijink BM, Leemans CR, van Dongen GA: (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab. J Nucl Med 2005, 46:1898-1906.
21. Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA: Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograftbearing nude mice. J Nucl Med 2003, 44:1663-1670.
22. Tanaka E, Ohnishi S, Laurence RG, Choi HS, Humblet V, Frangioni JV: Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence. J Urol 2007, 178:2197-2202.
23. Graves EE, Yessayan D, Turner G, Weissleder R, Ntziachristos V: Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography. J Biomed Opt 2005, 10:44019.
24. Gao M, Lewis G, Turner GM, Soubret A, Ntziachristos V: Effects of background fluorescence in fluorescence molecular tomography. Appl Opt 2005, 44:5468-5474.